An international Phase 2 trial will test BMS-986368 as a potentially new oral therapy for managing multiple sclerosis-related ...

Most people with MS who are treated with formulations of botulinum toxin to manage spasticity report being satisfied, a study ...

Spasticity in muscles can be due to nerve disorder in CNS, here are symptoms and treatment you should know about. Written by : Puru Bansal Updated at: Mar 28, 2022 17:46 IST ...

If spasticity is left untreated, then it could lead to certain complications that can impact rest of your life. In order to treat condition of spasticity, you need to follow some ways that ...

Researches at the University of Cincinnati's Gardner Neuroscience Institute could have discovered a new oral treatment that ...

Background OnabotulinumtoxinA has demonstrated significant benefit in adult focal spasticity. This study reviews the injection patterns (i.e., muscle distribution, dosing) of onabotulinumtoxinA ...

Spasticity was significantly evident in the HLI group compared to the LLI group (P=0.023). Six weeks post-injury, muscle CSA was 103±18 cm2 in the HLI group and 80±20 cm2 in the LLI group ...

Spasticity may be better measured with an appropriate battery of tests, including the AS or MAS, along with PSFS. These tools would benefit from further reliability and responsiveness testing.

Introduction. Spasticity is formally defined as a velocity-dependent increase in resistance to passive range of motion. It is a hallmark of neurological diseases that affect the central nervous ...